The significance of T-box transcription factor 5 and CD44s expression in NSCLC: correlation with prognostic markers. Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018
E-cadherin and beta-catenin expression in imprints of NSCLC. Relationship with prognostic parameters Source: Eur Respir J 2006; 28: Suppl. 50, 769s Year: 2006
Small cell lung cancer: prognostic significance and correlation with clinical and laboratory parameters Source: Eur Respir J 2007; 30: Suppl. 51, 670s Year: 2007
Studies on clinical significance and relationship with PI and gene protein expression of p16, Rb and Cyclin-D1 in lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002
KI67: Analysis of its expression and prognostic significance in a resected non small cell lung cancer population Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012
Identification of genes with diagnostic and prognostic value in lung cancer. Source: International Congress 2019 – Biology of lung cancer Year: 2019
Prognostic significance of three tumor markers (CA125, CEA, and TPA) in lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 73s Year: 2002
Immunohistocemical expression of P53 and BCL-2 in pateints with lung cancer: correlation with survival time Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006
Clinical significance of serum survivin, MGB-1 and Pref-1 levels during chemotherapy of lung cancer Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009
Elevation of circulating endothelial cell levels in lung cancer – a new prognostic and/or predictive marker? Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology Year: 2008
Prognostic significance and correlation between Akt phosphorylation and loss of PTEN protein expression in non-small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 458s Year: 2005
Distribution of BCL-2 gene expression and its prognostic value in non-small cell pulmonary cancer Source: Eur Respir J 2002; 20: Suppl. 38, 72s Year: 2002
Investigating new prognostic crossroads in lung carcinomas; comparing the prognostic potential of vascular endothelial growth factor (VEGF) and its receptors versus endoglin (CD105) Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009
The value of AXL expression in squamous cell carcinoma of the lung: relationship with clinicopathological parameters. Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017
Is YKL-40 a prognostic marker in sarcoidosis? Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010
Immunohistochemical expression of Bcl-2 and p53 in patients with lung cancer: Correlation with survival time Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012
Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer Source: Eur Respir J 2004; 23: 14-19 Year: 2004
Clinicopathological significance and prognostic importance of circulating plasma DNA expression in advanced non-small cell lung cancer and its efficacy as a diagnostic tool Source: Annual Congress 2012 - New insights in the pathology of lung cancer Year: 2012
The serum levels of endothelin (ET-1); an activation marker and prognostic indicator in sarcoidosis? Source: Eur Respir J 2005; 26: Suppl. 49, 80s Year: 2005
Analysis of surgical stage lung cancer and tumour markers prognostic value Source: Eur Respir J 2006; 28: Suppl. 50, 770s Year: 2006